AMETEK, Inc. Logo
About Us Company Profile What's New at ZYGO? Upcoming Events History Manufacturing Locations Sales/Service Offices Careers How to Get to ZYGO Patent Information ISO Registrations Conflict Minerals Policy Privacy and Cookie Policy Terms & Conditions
Please Note: Zygo Corporation is conducting business as usual; however most offices are closed to non-employees and are operating with reduced on-premises staffing in compliance with COVID-19 social distancing practices. Please contact us with any questions, and prior to shipping materials to any of our locations.

News Release
June 2, 2005

ZYGO Ships 150th Beam Delivery System for INTRALASE FS2 Femtosecond Laser

MIDDLEFIELD, CT, Jun 02, 2005 (MARKET WIRE via COMTEX) -- Zygo Corporation (NASDAQ: ZIGO) is pleased to announce it has shipped the 150th beam delivery system to IntraLase Corp., manufacturer of the INTRALASE FS(R) femtosecond laser used to create corneal flaps in the first step of LASIK surgery. ZYGO's beam delivery system consists of four high-precision electro-optic assemblies that deliver ultra-fast laser pulses to precisely calibrated depths below the surface of a patient's cornea. The ZYGO system enables real-time surgeon monitoring of the corneal flap procedure, in which the laser creates a pattern of thousands of microscopic bubbles within the stroma that separate tissue at the molecular level and create a corneal flap from the inside out.

"Delivery of the 150th beam delivery system clearly demonstrates the growing adoption of IntraLase's femtosecond laser technology as a new standard of care and is a notable achievement for both our companies," said Andrew Riser, Commercial Business Development Manager at ZYGO's Optics business segment (Costa Mesa, California and Tucson, Arizona). "This is an important milestone for ZYGO's new state-of-the-art production facilities, and a tribute to our world-leading capability in optical metrology. The fact that we can improve the quality of life for so many people also brings special satisfaction to our work," Riser added.

Charline Gauthier, O.D., Ph.D., Executive Vice President and Chief Operating Officer of IntraLase, commented that, "IntraLase is contributing to the advancement of LASIK surgery by enabling improved safety and visual outcomes for surgeons and patients. ZYGO's ability to meet delivery and technical performance requirements has significantly supported the successful deployment of our new laser technology around the world."

Also involved in the project was ZYGO's partner, Optical Research Associates (ORA)(R). Doug Nutter, VP of Business Development for ORA, commented, "We are pleased both with the success of IntraLase and with the Zygo/ORA partnership."

Zygo Corporation (NASDAQ: ZIGO), headquartered in Middlefield, Connecticut, is a worldwide supplier of optical metrology instruments, precision optics, and electro-optical design and manufacturing services, serving customers in the semiconductor capital equipment and industrial markets. See ZYGO's web site at for additional information.

IntraLase designs, develops, and manufactures an ultra-fast laser, related software and disposable devices used to create a corneal flap, the first step in LASIK surgery for the correction of vision. The company's products improve the safety, precision, and visual results of LASIK procedures by providing a computer-controlled laser solution in place of the hand-held mechanical, metal-bladed microkeratome traditionally used to create corneal flaps. IntraLase lasers are also used in surgical approaches to the treatment of diseased corneas. The company's lasers and disposable per-procedure patient interfaces are presently marketed throughout the United States and 17 other countries. IntraLase is headquartered and manufactures its products in Irvine, California. For additional information, visit the company's web site:

All statements other than statements of historical fact included in this news release regarding the Company's financial position, business strategy, plans, anticipated growth rates, and objectives of management of the Company for future operations are forward-looking statements. Forward-looking statements are intended to provide management's current expectations or plans for the future operating and financial performance of the Company based upon information currently available and assumptions currently believed to be valid. Forward-looking statements can be identified by the use of words such as "anticipate," "believe," "estimate," "expect," "intend," "plans," "strategy," "project," and other words of similar meaning in connection with a discussion of future operating or financial performance. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors. Among the important factors that could cause actual events to differ materially from those in the forward-looking statements are fluctuations in capital spending in the semiconductor industry, fluctuations in net sales to our major customer, manufacturing and supplier risks, dependence on new product development, rapid technological and market change, international operations, dependence on proprietary technology and key personnel, length of the sales cycle, environmental regulations, and changes in expected costs of discontinued operations. Further information on potential factors that could affect Zygo Corporation's business is described in the Company's reports on file with the Securities and Exchange Commission, including its Form 10-K for the fiscal year ended June 30, 2004.

Walter Shephard
Vice President, Finance, Chief Financial Officer, and Treasurer
Voice:  860-704-3955

SOURCE: Zygo Corporation
By continuing to use this site, you agree to our Privacy and Cookie Policy. OK

What's New at ZYGO?
Social Media Icons LinkedIn Twitter Facebook YouTube
National Flags
  Privacy and Cookie Policy        Privacy Policy Inquiry Form        Unsubscribe
× Enter the email address you would like to unsubscribe from future contact...


Or, if you have a question, please use our Privacy Policy Inquiry form.